nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—DPP4—type 2 diabetes mellitus	0.355	1	CbGaD
Adenosine—DPP4—Linagliptin—type 2 diabetes mellitus	0.235	0.529	CbGbCtD
Adenosine—DPP4—Sitagliptin—type 2 diabetes mellitus	0.21	0.471	CbGbCtD
Adenosine—ADA—brown adipose tissue—type 2 diabetes mellitus	0.00599	0.188	CbGeAlD
Adenosine—ADORA1—nerve—type 2 diabetes mellitus	0.00206	0.0646	CbGeAlD
Adenosine—SLC28A3—islet of Langerhans—type 2 diabetes mellitus	0.00195	0.0611	CbGeAlD
Adenosine—SLC28A3—pancreas—type 2 diabetes mellitus	0.00137	0.0429	CbGeAlD
Adenosine—SLC28A3—adipose tissue—type 2 diabetes mellitus	0.00124	0.039	CbGeAlD
Adenosine—ADK—islet of Langerhans—type 2 diabetes mellitus	0.00104	0.0325	CbGeAlD
Adenosine—DPP4—islet of Langerhans—type 2 diabetes mellitus	0.00101	0.0315	CbGeAlD
Adenosine—ADA—cardiovascular system—type 2 diabetes mellitus	0.000918	0.0288	CbGeAlD
Adenosine—ADK—retina—type 2 diabetes mellitus	0.000886	0.0278	CbGeAlD
Adenosine—ADORA2B—adipose tissue—type 2 diabetes mellitus	0.000885	0.0278	CbGeAlD
Adenosine—ADORA2A—cardiovascular system—type 2 diabetes mellitus	0.000835	0.0262	CbGeAlD
Adenosine—ADK—nephron tubule—type 2 diabetes mellitus	0.000835	0.0262	CbGeAlD
Adenosine—DPP4—nephron tubule—type 2 diabetes mellitus	0.000809	0.0254	CbGeAlD
Adenosine—ADA—adipose tissue—type 2 diabetes mellitus	0.000809	0.0254	CbGeAlD
Adenosine—ADK—cardiovascular system—type 2 diabetes mellitus	0.00075	0.0235	CbGeAlD
Adenosine—ADK—kidney—type 2 diabetes mellitus	0.000734	0.023	CbGeAlD
Adenosine—ADK—pancreas—type 2 diabetes mellitus	0.000729	0.0229	CbGeAlD
Adenosine—DPP4—cardiovascular system—type 2 diabetes mellitus	0.000727	0.0228	CbGeAlD
Adenosine—ADORA1—cardiovascular system—type 2 diabetes mellitus	0.000721	0.0226	CbGeAlD
Adenosine—ADK—cortex of kidney—type 2 diabetes mellitus	0.000714	0.0224	CbGeAlD
Adenosine—DPP4—kidney—type 2 diabetes mellitus	0.000711	0.0223	CbGeAlD
Adenosine—DPP4—pancreas—type 2 diabetes mellitus	0.000706	0.0222	CbGeAlD
Adenosine—ADORA1—kidney—type 2 diabetes mellitus	0.000705	0.0221	CbGeAlD
Adenosine—DPP4—cortex of kidney—type 2 diabetes mellitus	0.000693	0.0217	CbGeAlD
Adenosine—ADORA1—cortex of kidney—type 2 diabetes mellitus	0.000687	0.0216	CbGeAlD
Adenosine—S-Adenosylmethionine—MAT1A—type 2 diabetes mellitus	0.000684	0.16	CrCbGaD
Adenosine—ADK—adipose tissue—type 2 diabetes mellitus	0.000661	0.0207	CbGeAlD
Adenosine—DPP4—adipose tissue—type 2 diabetes mellitus	0.000641	0.0201	CbGeAlD
Adenosine—ADORA1—adipose tissue—type 2 diabetes mellitus	0.000636	0.0199	CbGeAlD
Adenosine—Ribavirin—ENPP1—type 2 diabetes mellitus	0.000631	0.148	CrCbGaD
Adenosine—ADORA2A—liver—type 2 diabetes mellitus	0.000516	0.0162	CbGeAlD
Adenosine—ADK—liver—type 2 diabetes mellitus	0.000464	0.0145	CbGeAlD
Adenosine—DPP4—liver—type 2 diabetes mellitus	0.000449	0.0141	CbGeAlD
Adenosine—S-Adenosylmethionine—CBS—type 2 diabetes mellitus	0.000441	0.103	CrCbGaD
Adenosine—Azacitidine—DNMT1—type 2 diabetes mellitus	0.000329	0.0769	CrCbGaD
Adenosine—Decitabine—DNMT1—type 2 diabetes mellitus	0.000321	0.0751	CrCbGaD
Adenosine—Adenosine monophosphate—PRKAA1—type 2 diabetes mellitus	0.00028	0.0654	CrCbGaD
Adenosine—Vidarabine—DPP4—type 2 diabetes mellitus	0.000278	0.065	CrCbGaD
Adenosine—Adenosine triphosphate—PRKAA1—type 2 diabetes mellitus	0.000243	0.0567	CrCbGaD
Adenosine—Glucosamine—MMP9—type 2 diabetes mellitus	0.000178	0.0417	CrCbGaD
Adenosine—Adenosine triphosphate—ABCC8—type 2 diabetes mellitus	0.000143	0.0334	CrCbGaD
Adenosine—Flushing—Irbesartan—type 2 diabetes mellitus	0.00013	0.00141	CcSEcCtD
Adenosine—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00013	0.00141	CcSEcCtD
Adenosine—Angioedema—Valsartan—type 2 diabetes mellitus	0.00013	0.0014	CcSEcCtD
Adenosine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000129	0.00139	CcSEcCtD
Adenosine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000129	0.00139	CcSEcCtD
Adenosine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000128	0.00139	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000128	0.00138	CcSEcCtD
Adenosine—Syncope—Valsartan—type 2 diabetes mellitus	0.000128	0.00138	CcSEcCtD
Adenosine—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000127	0.00137	CcSEcCtD
Adenosine—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000127	0.00137	CcSEcCtD
Adenosine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000126	0.00136	CcSEcCtD
Adenosine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000126	0.00136	CcSEcCtD
Adenosine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000126	0.00136	CcSEcCtD
Adenosine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000126	0.00136	CcSEcCtD
Adenosine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000125	0.00135	CcSEcCtD
Adenosine—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000125	0.00135	CcSEcCtD
Adenosine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000125	0.00135	CcSEcCtD
Adenosine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000125	0.00135	CcSEcCtD
Adenosine—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000124	0.00134	CcSEcCtD
Adenosine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000124	0.00134	CcSEcCtD
Adenosine—Cough—Valsartan—type 2 diabetes mellitus	0.000124	0.00134	CcSEcCtD
Adenosine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000124	0.00134	CcSEcCtD
Adenosine—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000124	0.00134	CcSEcCtD
Adenosine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000123	0.00133	CcSEcCtD
Adenosine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000123	0.00133	CcSEcCtD
Adenosine—Cough—Orlistat—type 2 diabetes mellitus	0.000123	0.00132	CcSEcCtD
Adenosine—Flushing—Losartan—type 2 diabetes mellitus	0.000123	0.00132	CcSEcCtD
Adenosine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000122	0.00132	CcSEcCtD
Adenosine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000122	0.00132	CcSEcCtD
Adenosine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000122	0.00132	CcSEcCtD
Adenosine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000122	0.00132	CcSEcCtD
Adenosine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000122	0.00132	CcSEcCtD
Adenosine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000122	0.00131	CcSEcCtD
Adenosine—Tremor—Metformin—type 2 diabetes mellitus	0.000121	0.00131	CcSEcCtD
Adenosine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000121	0.00131	CcSEcCtD
Adenosine—Sweating—Ramipril—type 2 diabetes mellitus	0.000121	0.00131	CcSEcCtD
Adenosine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000121	0.00131	CcSEcCtD
Adenosine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000121	0.0013	CcSEcCtD
Adenosine—Tension—Irbesartan—type 2 diabetes mellitus	0.00012	0.0013	CcSEcCtD
Adenosine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.00012	0.00129	CcSEcCtD
Adenosine—Chest pain—Orlistat—type 2 diabetes mellitus	0.00012	0.00129	CcSEcCtD
Adenosine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000119	0.00129	CcSEcCtD
Adenosine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000119	0.00128	CcSEcCtD
Adenosine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000118	0.00128	CcSEcCtD
Adenosine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000118	0.00128	CcSEcCtD
Adenosine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000118	0.00127	CcSEcCtD
Adenosine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000118	0.00127	CcSEcCtD
Adenosine—Glucosamine—TNF—type 2 diabetes mellitus	0.000117	0.0274	CrCbGaD
Adenosine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000117	0.00126	CcSEcCtD
Adenosine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000116	0.00126	CcSEcCtD
Adenosine—Syncope—Metformin—type 2 diabetes mellitus	0.000116	0.00125	CcSEcCtD
Adenosine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000116	0.00125	CcSEcCtD
Adenosine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000116	0.00125	CcSEcCtD
Adenosine—Rash—Glipizide—type 2 diabetes mellitus	0.000115	0.00124	CcSEcCtD
Adenosine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000115	0.00124	CcSEcCtD
Adenosine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000115	0.00124	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000115	0.00124	CcSEcCtD
Adenosine—Adenosine triphosphate—AKT1—type 2 diabetes mellitus	0.000115	0.0268	CrCbGaD
Adenosine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000115	0.00124	CcSEcCtD
Adenosine—Headache—Glipizide—type 2 diabetes mellitus	0.000115	0.00124	CcSEcCtD
Adenosine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000114	0.00124	CcSEcCtD
Adenosine—Palpitations—Metformin—type 2 diabetes mellitus	0.000114	0.00124	CcSEcCtD
Adenosine—Shock—Valsartan—type 2 diabetes mellitus	0.000114	0.00123	CcSEcCtD
Adenosine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000114	0.00123	CcSEcCtD
Adenosine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000113	0.00123	CcSEcCtD
Adenosine—Adenosine monophosphate—SRC—type 2 diabetes mellitus	0.000113	0.0264	CrCbGaD
Adenosine—Tension—Losartan—type 2 diabetes mellitus	0.000113	0.00122	CcSEcCtD
Adenosine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000113	0.00122	CcSEcCtD
Adenosine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000113	0.00122	CcSEcCtD
Adenosine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000113	0.00122	CcSEcCtD
Adenosine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000112	0.00121	CcSEcCtD
Adenosine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000112	0.00121	CcSEcCtD
Adenosine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000112	0.00121	CcSEcCtD
Adenosine—Hypertension—Metformin—type 2 diabetes mellitus	0.000112	0.00121	CcSEcCtD
Adenosine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000112	0.00121	CcSEcCtD
Adenosine—Nervousness—Losartan—type 2 diabetes mellitus	0.000112	0.00121	CcSEcCtD
Adenosine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000112	0.00121	CcSEcCtD
Adenosine—Back pain—Losartan—type 2 diabetes mellitus	0.000111	0.0012	CcSEcCtD
Adenosine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000111	0.0012	CcSEcCtD
Adenosine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00011	0.00119	CcSEcCtD
Adenosine—Chest pain—Metformin—type 2 diabetes mellitus	0.00011	0.00119	CcSEcCtD
Adenosine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00011	0.00118	CcSEcCtD
Adenosine—Syncope—Irbesartan—type 2 diabetes mellitus	0.00011	0.00118	CcSEcCtD
Adenosine—Discomfort—Metformin—type 2 diabetes mellitus	0.000109	0.00118	CcSEcCtD
Adenosine—Nausea—Glipizide—type 2 diabetes mellitus	0.000109	0.00117	CcSEcCtD
Adenosine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000108	0.00117	CcSEcCtD
Adenosine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000108	0.00117	CcSEcCtD
Adenosine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000108	0.00117	CcSEcCtD
Adenosine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000108	0.00117	CcSEcCtD
Adenosine—Pain—Gliclazide—type 2 diabetes mellitus	0.000108	0.00117	CcSEcCtD
Adenosine—Tremor—Losartan—type 2 diabetes mellitus	0.000108	0.00116	CcSEcCtD
Adenosine—Rash—Glimepiride—type 2 diabetes mellitus	0.000108	0.00116	CcSEcCtD
Adenosine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000107	0.00116	CcSEcCtD
Adenosine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000107	0.00116	CcSEcCtD
Adenosine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000107	0.00116	CcSEcCtD
Adenosine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000107	0.00116	CcSEcCtD
Adenosine—Headache—Glimepiride—type 2 diabetes mellitus	0.000107	0.00115	CcSEcCtD
Adenosine—Cough—Irbesartan—type 2 diabetes mellitus	0.000107	0.00115	CcSEcCtD
Adenosine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000107	0.00115	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000106	0.00114	CcSEcCtD
Adenosine—Agitation—Losartan—type 2 diabetes mellitus	0.000106	0.00114	CcSEcCtD
Adenosine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000106	0.00114	CcSEcCtD
Adenosine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000106	0.00114	CcSEcCtD
Adenosine—Flushing—Ramipril—type 2 diabetes mellitus	0.000105	0.00114	CcSEcCtD
Adenosine—Angioedema—Losartan—type 2 diabetes mellitus	0.000105	0.00114	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000104	0.00113	CcSEcCtD
Adenosine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000104	0.00113	CcSEcCtD
Adenosine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000104	0.00112	CcSEcCtD
Adenosine—Shock—Metformin—type 2 diabetes mellitus	0.000104	0.00112	CcSEcCtD
Adenosine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000104	0.00112	CcSEcCtD
Adenosine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000104	0.00112	CcSEcCtD
Adenosine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000103	0.00112	CcSEcCtD
Adenosine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000103	0.00111	CcSEcCtD
Adenosine—Syncope—Losartan—type 2 diabetes mellitus	0.000103	0.00111	CcSEcCtD
Adenosine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000103	0.00111	CcSEcCtD
Adenosine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000103	0.00111	CcSEcCtD
Adenosine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000102	0.0011	CcSEcCtD
Adenosine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000102	0.0011	CcSEcCtD
Adenosine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000102	0.0011	CcSEcCtD
Adenosine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000102	0.0011	CcSEcCtD
Adenosine—Palpitations—Losartan—type 2 diabetes mellitus	0.000102	0.0011	CcSEcCtD
Adenosine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000101	0.00109	CcSEcCtD
Adenosine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000101	0.00109	CcSEcCtD
Adenosine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000101	0.00109	CcSEcCtD
Adenosine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000101	0.00109	CcSEcCtD
Adenosine—Tenofovir—ABCC2—type 2 diabetes mellitus	0.000101	0.0236	CrCbGaD
Adenosine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000101	0.00109	CcSEcCtD
Adenosine—Cough—Losartan—type 2 diabetes mellitus	0.0001	0.00108	CcSEcCtD
Adenosine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.0001	0.00108	CcSEcCtD
Adenosine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.97e-05	0.00108	CcSEcCtD
Adenosine—Hypotension—Metformin—type 2 diabetes mellitus	9.88e-05	0.00107	CcSEcCtD
Adenosine—Shock—Irbesartan—type 2 diabetes mellitus	9.81e-05	0.00106	CcSEcCtD
Adenosine—Pain—Orlistat—type 2 diabetes mellitus	9.81e-05	0.00106	CcSEcCtD
Adenosine—Chest pain—Losartan—type 2 diabetes mellitus	9.79e-05	0.00106	CcSEcCtD
Adenosine—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.78e-05	0.00106	CcSEcCtD
Adenosine—Anxiety—Losartan—type 2 diabetes mellitus	9.76e-05	0.00105	CcSEcCtD
Adenosine—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.00105	CcSEcCtD
Adenosine—Rash—Bromocriptine—type 2 diabetes mellitus	9.7e-05	0.00105	CcSEcCtD
Adenosine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.69e-05	0.00105	CcSEcCtD
Adenosine—Tension—Ramipril—type 2 diabetes mellitus	9.68e-05	0.00105	CcSEcCtD
Adenosine—Discomfort—Losartan—type 2 diabetes mellitus	9.67e-05	0.00104	CcSEcCtD
Adenosine—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.66e-05	0.00104	CcSEcCtD
Adenosine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.64e-05	0.00104	CcSEcCtD
Adenosine—Headache—Bromocriptine—type 2 diabetes mellitus	9.64e-05	0.00104	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9.63e-05	0.00104	CcSEcCtD
Adenosine—Nervousness—Ramipril—type 2 diabetes mellitus	9.58e-05	0.00103	CcSEcCtD
Adenosine—Dry mouth—Losartan—type 2 diabetes mellitus	9.58e-05	0.00103	CcSEcCtD
Adenosine—Paraesthesia—Metformin—type 2 diabetes mellitus	9.49e-05	0.00102	CcSEcCtD
Adenosine—Dyspnoea—Metformin—type 2 diabetes mellitus	9.42e-05	0.00102	CcSEcCtD
Adenosine—Somnolence—Metformin—type 2 diabetes mellitus	9.4e-05	0.00101	CcSEcCtD
Adenosine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	9.39e-05	0.00101	CcSEcCtD
Adenosine—Hypotension—Irbesartan—type 2 diabetes mellitus	9.32e-05	0.00101	CcSEcCtD
Adenosine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	9.31e-05	0.00101	CcSEcCtD
Adenosine—Tremor—Ramipril—type 2 diabetes mellitus	9.24e-05	0.000998	CcSEcCtD
Adenosine—Shock—Losartan—type 2 diabetes mellitus	9.23e-05	0.000997	CcSEcCtD
Adenosine—Urticaria—Valsartan—type 2 diabetes mellitus	9.22e-05	0.000996	CcSEcCtD
Adenosine—Tachycardia—Losartan—type 2 diabetes mellitus	9.16e-05	0.000989	CcSEcCtD
Adenosine—Nausea—Bromocriptine—type 2 diabetes mellitus	9.14e-05	0.000987	CcSEcCtD
Adenosine—Urticaria—Orlistat—type 2 diabetes mellitus	9.11e-05	0.000984	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000981	CcSEcCtD
Adenosine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	9.07e-05	0.00098	CcSEcCtD
Adenosine—Asthenia—Gliclazide—type 2 diabetes mellitus	9.06e-05	0.000979	CcSEcCtD
Adenosine—Agitation—Ramipril—type 2 diabetes mellitus	9.06e-05	0.000979	CcSEcCtD
Adenosine—Glucosamine—CYP2E1—type 2 diabetes mellitus	9.03e-05	0.0211	CrCbGaD
Adenosine—Angioedema—Ramipril—type 2 diabetes mellitus	9.01e-05	0.000973	CcSEcCtD
Adenosine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.96e-05	0.000967	CcSEcCtD
Adenosine—Vomiting—Glyburide—type 2 diabetes mellitus	8.94e-05	0.000966	CcSEcCtD
Adenosine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.89e-05	0.00096	CcSEcCtD
Adenosine—Rash—Glyburide—type 2 diabetes mellitus	8.87e-05	0.000958	CcSEcCtD
Adenosine—Somnolence—Irbesartan—type 2 diabetes mellitus	8.87e-05	0.000958	CcSEcCtD
Adenosine—Dermatitis—Glyburide—type 2 diabetes mellitus	8.86e-05	0.000957	CcSEcCtD
Adenosine—Syncope—Ramipril—type 2 diabetes mellitus	8.84e-05	0.000955	CcSEcCtD
Adenosine—Headache—Glyburide—type 2 diabetes mellitus	8.81e-05	0.000952	CcSEcCtD
Adenosine—Hypotension—Losartan—type 2 diabetes mellitus	8.77e-05	0.000947	CcSEcCtD
Adenosine—Palpitations—Ramipril—type 2 diabetes mellitus	8.71e-05	0.000941	CcSEcCtD
Adenosine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.67e-05	0.000936	CcSEcCtD
Adenosine—Cough—Ramipril—type 2 diabetes mellitus	8.61e-05	0.000929	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	8.55e-05	0.000924	CcSEcCtD
Adenosine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	8.55e-05	0.000924	CcSEcCtD
Adenosine—Convulsion—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000923	CcSEcCtD
Adenosine—Pain—Irbesartan—type 2 diabetes mellitus	8.53e-05	0.000921	CcSEcCtD
Adenosine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	8.45e-05	0.000913	CcSEcCtD
Adenosine—Paraesthesia—Losartan—type 2 diabetes mellitus	8.43e-05	0.00091	CcSEcCtD
Adenosine—Urticaria—Metformin—type 2 diabetes mellitus	8.4e-05	0.000907	CcSEcCtD
Adenosine—Chest pain—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000907	CcSEcCtD
Adenosine—Dyspnoea—Losartan—type 2 diabetes mellitus	8.37e-05	0.000904	CcSEcCtD
Adenosine—Anxiety—Ramipril—type 2 diabetes mellitus	8.37e-05	0.000904	CcSEcCtD
Adenosine—Nausea—Glyburide—type 2 diabetes mellitus	8.36e-05	0.000903	CcSEcCtD
Adenosine—Dizziness—Gliclazide—type 2 diabetes mellitus	8.35e-05	0.000902	CcSEcCtD
Adenosine—Somnolence—Losartan—type 2 diabetes mellitus	8.34e-05	0.000901	CcSEcCtD
Adenosine—Asthenia—Valsartan—type 2 diabetes mellitus	8.33e-05	0.000899	CcSEcCtD
Adenosine—Discomfort—Ramipril—type 2 diabetes mellitus	8.3e-05	0.000896	CcSEcCtD
Adenosine—Asthenia—Orlistat—type 2 diabetes mellitus	8.23e-05	0.000889	CcSEcCtD
Adenosine—Dry mouth—Ramipril—type 2 diabetes mellitus	8.21e-05	0.000887	CcSEcCtD
Adenosine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.05e-05	0.000869	CcSEcCtD
Adenosine—Vomiting—Gliclazide—type 2 diabetes mellitus	8.03e-05	0.000867	CcSEcCtD
Adenosine—Pain—Losartan—type 2 diabetes mellitus	8.03e-05	0.000867	CcSEcCtD
Adenosine—Rash—Gliclazide—type 2 diabetes mellitus	7.96e-05	0.00086	CcSEcCtD
Adenosine—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.96e-05	0.000859	CcSEcCtD
Adenosine—Urticaria—Irbesartan—type 2 diabetes mellitus	7.92e-05	0.000856	CcSEcCtD
Adenosine—Shock—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000855	CcSEcCtD
Adenosine—Headache—Gliclazide—type 2 diabetes mellitus	7.91e-05	0.000855	CcSEcCtD
Adenosine—Tachycardia—Ramipril—type 2 diabetes mellitus	7.86e-05	0.000848	CcSEcCtD
Adenosine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.78e-05	0.00084	CcSEcCtD
Adenosine—Dizziness—Valsartan—type 2 diabetes mellitus	7.67e-05	0.000829	CcSEcCtD
Adenosine—Dizziness—Orlistat—type 2 diabetes mellitus	7.58e-05	0.000819	CcSEcCtD
Adenosine—Asthenia—Metformin—type 2 diabetes mellitus	7.58e-05	0.000819	CcSEcCtD
Adenosine—Hypotension—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000812	CcSEcCtD
Adenosine—Nausea—Gliclazide—type 2 diabetes mellitus	7.5e-05	0.00081	CcSEcCtD
Adenosine—Urticaria—Losartan—type 2 diabetes mellitus	7.46e-05	0.000805	CcSEcCtD
Adenosine—Vomiting—Valsartan—type 2 diabetes mellitus	7.38e-05	0.000797	CcSEcCtD
Adenosine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.35e-05	0.000794	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.33e-05	0.000792	CcSEcCtD
Adenosine—Rash—Valsartan—type 2 diabetes mellitus	7.32e-05	0.00079	CcSEcCtD
Adenosine—Dermatitis—Valsartan—type 2 diabetes mellitus	7.31e-05	0.00079	CcSEcCtD
Adenosine—Vomiting—Orlistat—type 2 diabetes mellitus	7.29e-05	0.000788	CcSEcCtD
Adenosine—Headache—Valsartan—type 2 diabetes mellitus	7.27e-05	0.000785	CcSEcCtD
Adenosine—Rash—Orlistat—type 2 diabetes mellitus	7.23e-05	0.000781	CcSEcCtD
Adenosine—Paraesthesia—Ramipril—type 2 diabetes mellitus	7.23e-05	0.000781	CcSEcCtD
Adenosine—Dermatitis—Orlistat—type 2 diabetes mellitus	7.22e-05	0.00078	CcSEcCtD
Adenosine—Headache—Orlistat—type 2 diabetes mellitus	7.18e-05	0.000776	CcSEcCtD
Adenosine—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000775	CcSEcCtD
Adenosine—Asthenia—Irbesartan—type 2 diabetes mellitus	7.16e-05	0.000773	CcSEcCtD
Adenosine—Somnolence—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000773	CcSEcCtD
Adenosine—Dizziness—Metformin—type 2 diabetes mellitus	6.99e-05	0.000755	CcSEcCtD
Adenosine—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.92e-05	0.000747	CcSEcCtD
Adenosine—Nausea—Valsartan—type 2 diabetes mellitus	6.89e-05	0.000745	CcSEcCtD
Adenosine—Nausea—Orlistat—type 2 diabetes mellitus	6.81e-05	0.000736	CcSEcCtD
Adenosine—Tenofovir—CYP1A2—type 2 diabetes mellitus	6.74e-05	0.0158	CrCbGaD
Adenosine—Asthenia—Losartan—type 2 diabetes mellitus	6.73e-05	0.000727	CcSEcCtD
Adenosine—Vomiting—Metformin—type 2 diabetes mellitus	6.72e-05	0.000726	CcSEcCtD
Adenosine—Rash—Metformin—type 2 diabetes mellitus	6.66e-05	0.00072	CcSEcCtD
Adenosine—Dermatitis—Metformin—type 2 diabetes mellitus	6.66e-05	0.000719	CcSEcCtD
Adenosine—Headache—Metformin—type 2 diabetes mellitus	6.62e-05	0.000715	CcSEcCtD
Adenosine—Dizziness—Irbesartan—type 2 diabetes mellitus	6.6e-05	0.000712	CcSEcCtD
Adenosine—Urticaria—Ramipril—type 2 diabetes mellitus	6.39e-05	0.000691	CcSEcCtD
Adenosine—Vomiting—Irbesartan—type 2 diabetes mellitus	6.34e-05	0.000685	CcSEcCtD
Adenosine—Rash—Irbesartan—type 2 diabetes mellitus	6.29e-05	0.000679	CcSEcCtD
Adenosine—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.28e-05	0.000679	CcSEcCtD
Adenosine—Nausea—Metformin—type 2 diabetes mellitus	6.28e-05	0.000678	CcSEcCtD
Adenosine—Headache—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000675	CcSEcCtD
Adenosine—Dizziness—Losartan—type 2 diabetes mellitus	6.21e-05	0.00067	CcSEcCtD
Adenosine—S-Adenosylmethionine—CYP2E1—type 2 diabetes mellitus	6.19e-05	0.0145	CrCbGaD
Adenosine—Vomiting—Losartan—type 2 diabetes mellitus	5.97e-05	0.000645	CcSEcCtD
Adenosine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.93e-05	0.00064	CcSEcCtD
Adenosine—Nausea—Irbesartan—type 2 diabetes mellitus	5.92e-05	0.00064	CcSEcCtD
Adenosine—Rash—Losartan—type 2 diabetes mellitus	5.92e-05	0.000639	CcSEcCtD
Adenosine—Dermatitis—Losartan—type 2 diabetes mellitus	5.91e-05	0.000639	CcSEcCtD
Adenosine—Headache—Losartan—type 2 diabetes mellitus	5.88e-05	0.000635	CcSEcCtD
Adenosine—Asthenia—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000624	CcSEcCtD
Adenosine—Nausea—Losartan—type 2 diabetes mellitus	5.58e-05	0.000602	CcSEcCtD
Adenosine—Adenosine triphosphate—ABCC2—type 2 diabetes mellitus	5.45e-05	0.0127	CrCbGaD
Adenosine—Dizziness—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000575	CcSEcCtD
Adenosine—Vomiting—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000553	CcSEcCtD
Adenosine—Rash—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000548	CcSEcCtD
Adenosine—Dermatitis—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000548	CcSEcCtD
Adenosine—Headache—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000545	CcSEcCtD
Adenosine—Nausea—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000516	CcSEcCtD
Adenosine—Cytarabine—CYP3A4—type 2 diabetes mellitus	3.08e-05	0.00719	CrCbGaD
Adenosine—ADORA1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.4e-05	0.000196	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	1.39e-05	0.000196	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.39e-05	0.000196	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.39e-05	0.000195	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.38e-05	0.000195	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	1.38e-05	0.000195	CbGpPWpGaD
Adenosine—ADA—Metabolism—ADCY5—type 2 diabetes mellitus	1.38e-05	0.000194	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.38e-05	0.000194	CbGpPWpGaD
Adenosine—ADA—Metabolism—GPX1—type 2 diabetes mellitus	1.37e-05	0.000193	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AVP—type 2 diabetes mellitus	1.36e-05	0.000192	CbGpPWpGaD
Adenosine—ADK—Metabolism—ALB—type 2 diabetes mellitus	1.36e-05	0.000191	CbGpPWpGaD
Adenosine—ADA—Metabolism—CD36—type 2 diabetes mellitus	1.34e-05	0.000188	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.33e-05	0.000188	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.33e-05	0.000188	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.33e-05	0.000187	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.32e-05	0.000186	CbGpPWpGaD
Adenosine—ADA—Metabolism—PPP2CA—type 2 diabetes mellitus	1.32e-05	0.000186	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.31e-05	0.000184	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GCG—type 2 diabetes mellitus	1.31e-05	0.000184	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—IL6—type 2 diabetes mellitus	1.3e-05	0.000184	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3R1—type 2 diabetes mellitus	1.3e-05	0.000183	CbGpPWpGaD
Adenosine—ADK—Metabolism—NOS3—type 2 diabetes mellitus	1.3e-05	0.000183	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	1.3e-05	0.000183	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.29e-05	0.000181	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.29e-05	0.000181	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.29e-05	0.000181	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.29e-05	0.000181	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.29e-05	0.000181	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.29e-05	0.000181	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—EGFR—type 2 diabetes mellitus	1.28e-05	0.00018	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—type 2 diabetes mellitus	1.28e-05	0.00018	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.27e-05	0.000179	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.27e-05	0.000179	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.27e-05	0.000178	CbGpPWpGaD
Adenosine—ADA—Metabolism—MTHFR—type 2 diabetes mellitus	1.27e-05	0.000178	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	1.26e-05	0.000177	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.25e-05	0.000176	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.25e-05	0.000175	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.25e-05	0.000175	CbGpPWpGaD
Adenosine—ADA—Metabolism—PPARA—type 2 diabetes mellitus	1.24e-05	0.000175	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.24e-05	0.000175	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.24e-05	0.000175	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AVP—type 2 diabetes mellitus	1.24e-05	0.000174	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	1.24e-05	0.000174	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	1.23e-05	0.000173	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.23e-05	0.000173	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.22e-05	0.000172	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.22e-05	0.000172	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.22e-05	0.000171	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.22e-05	0.000171	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.21e-05	0.00017	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.2e-05	0.000169	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.2e-05	0.000169	CbGpPWpGaD
Adenosine—ADA—Metabolism—AGT—type 2 diabetes mellitus	1.2e-05	0.000169	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTGS2—type 2 diabetes mellitus	1.19e-05	0.000167	CbGpPWpGaD
Adenosine—ADA—Metabolism—CALM1—type 2 diabetes mellitus	1.18e-05	0.000166	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—type 2 diabetes mellitus	1.18e-05	0.000166	CbGpPWpGaD
Adenosine—ADA—Metabolism—APOE—type 2 diabetes mellitus	1.18e-05	0.000166	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.18e-05	0.000166	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.17e-05	0.000165	CbGpPWpGaD
Adenosine—ADA—Metabolism—APOA1—type 2 diabetes mellitus	1.17e-05	0.000164	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.16e-05	0.000163	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.14e-05	0.00016	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.13e-05	0.00016	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.13e-05	0.000159	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.12e-05	0.000157	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AVP—type 2 diabetes mellitus	1.11e-05	0.000157	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.11e-05	0.000157	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.11e-05	0.000157	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.11e-05	0.000157	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.11e-05	0.000156	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.11e-05	0.000156	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.11e-05	0.000155	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.1e-05	0.000155	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.1e-05	0.000154	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.09e-05	0.000154	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—INSR—type 2 diabetes mellitus	1.09e-05	0.000154	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.09e-05	0.000154	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOB—type 2 diabetes mellitus	1.08e-05	0.000152	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.08e-05	0.000152	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.07e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.07e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.07e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.07e-05	0.00015	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.06e-05	0.000149	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.05e-05	0.000148	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.04e-05	0.000147	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—C3—type 2 diabetes mellitus	1.03e-05	0.000145	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LPL—type 2 diabetes mellitus	1.03e-05	0.000145	CbGpPWpGaD
Adenosine—ADA—Metabolism—PPARG—type 2 diabetes mellitus	1.03e-05	0.000144	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.02e-05	0.000144	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.02e-05	0.000144	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.02e-05	0.000144	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.01e-05	0.000142	CbGpPWpGaD
Adenosine—ADA—Metabolism—INS—type 2 diabetes mellitus	1.01e-05	0.000142	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	9.95e-06	0.00014	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	9.93e-06	0.00014	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	9.93e-06	0.00014	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6—type 2 diabetes mellitus	9.84e-06	0.000138	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AGT—type 2 diabetes mellitus	9.78e-06	0.000138	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	9.7e-06	0.000136	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.66e-06	0.000136	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.65e-06	0.000136	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	9.62e-06	0.000135	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.61e-06	0.000135	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.61e-06	0.000135	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.48e-06	0.000133	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AVP—type 2 diabetes mellitus	9.48e-06	0.000133	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.48e-06	0.000133	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.45e-06	0.000133	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.44e-06	0.000133	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.41e-06	0.000132	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.41e-06	0.000132	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.4e-06	0.000132	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.3e-06	0.000131	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.3e-06	0.000131	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—C3—type 2 diabetes mellitus	9.26e-06	0.00013	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALB—type 2 diabetes mellitus	9.23e-06	0.00013	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOB—type 2 diabetes mellitus	9.16e-06	0.000129	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.12e-06	0.000128	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—AKT1—type 2 diabetes mellitus	9.08e-06	0.000128	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.04e-06	0.000127	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.02e-06	0.000127	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.83e-06	0.000124	CbGpPWpGaD
Adenosine—ADA—Metabolism—NOS3—type 2 diabetes mellitus	8.83e-06	0.000124	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3R1—type 2 diabetes mellitus	8.83e-06	0.000124	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.81e-06	0.000124	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AGT—type 2 diabetes mellitus	8.8e-06	0.000124	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.75e-06	0.000123	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LPL—type 2 diabetes mellitus	8.75e-06	0.000123	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.71e-06	0.000123	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.65e-06	0.000122	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LEP—type 2 diabetes mellitus	8.62e-06	0.000121	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOE—type 2 diabetes mellitus	8.62e-06	0.000121	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GCG—type 2 diabetes mellitus	8.61e-06	0.000121	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.61e-06	0.000121	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.56e-06	0.00012	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.52e-06	0.00012	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.47e-06	0.000119	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.44e-06	0.000119	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.21e-06	0.000115	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.13e-06	0.000114	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—type 2 diabetes mellitus	8.08e-06	0.000114	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.06e-06	0.000113	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.06e-06	0.000113	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.91e-06	0.000111	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.91e-06	0.000111	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—C3—type 2 diabetes mellitus	7.88e-06	0.000111	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.69e-06	0.000108	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.51e-06	0.000106	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.49e-06	0.000105	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.49e-06	0.000105	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AGT—type 2 diabetes mellitus	7.48e-06	0.000105	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.42e-06	0.000104	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—INS—type 2 diabetes mellitus	7.37e-06	0.000104	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.36e-06	0.000104	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LEP—type 2 diabetes mellitus	7.33e-06	0.000103	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOE—type 2 diabetes mellitus	7.33e-06	0.000103	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AVP—type 2 diabetes mellitus	7.32e-06	0.000103	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.32e-06	0.000103	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.29e-06	0.000102	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.25e-06	0.000102	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.25e-06	0.000102	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.25e-06	0.000102	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.18e-06	0.000101	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.13e-06	0.0001	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.12e-06	0.0001	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.09e-06	9.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOB—type 2 diabetes mellitus	7.07e-06	9.95e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.04e-06	9.91e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.96e-06	9.79e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.91e-06	9.73e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.77e-06	9.52e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LPL—type 2 diabetes mellitus	6.75e-06	9.5e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.61e-06	9.3e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.54e-06	9.2e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.46e-06	9.09e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.46e-06	9.09e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.34e-06	8.91e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—INS—type 2 diabetes mellitus	6.26e-06	8.81e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.22e-06	8.75e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.16e-06	8.67e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	6.08e-06	8.55e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—C3—type 2 diabetes mellitus	6.08e-06	8.55e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.06e-06	8.52e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.05e-06	8.52e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.03e-06	8.48e-05	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKT1—type 2 diabetes mellitus	5.97e-06	8.4e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.8e-06	8.16e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.79e-06	8.14e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	5.78e-06	8.13e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.75e-06	8.09e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.68e-06	7.99e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	5.66e-06	7.96e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	5.66e-06	7.96e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.6e-06	7.87e-05	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.54e-06	7.79e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.49e-06	7.73e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.49e-06	7.73e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.48e-06	7.72e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.45e-06	7.67e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.34e-06	7.51e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.18e-06	7.29e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.17e-06	7.27e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.13e-06	7.21e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.05e-06	7.1e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.03e-06	7.07e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—INS—type 2 diabetes mellitus	4.84e-06	6.8e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	4.78e-06	6.72e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.76e-06	6.69e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.71e-06	6.62e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.68e-06	6.58e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.67e-06	6.58e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.66e-06	6.56e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.65e-06	6.55e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.65e-06	6.55e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.63e-06	6.52e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.44e-06	6.25e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.41e-06	6.2e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.36e-06	6.13e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.27e-06	6.01e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.27e-06	6.01e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.24e-06	5.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.24e-06	5.97e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.19e-06	5.89e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.06e-06	5.72e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKT1—type 2 diabetes mellitus	4.06e-06	5.71e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.99e-06	5.62e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.96e-06	5.57e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.63e-06	5.11e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.63e-06	5.11e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.6e-06	5.07e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.58e-06	5.03e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.56e-06	5.01e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.4e-06	4.79e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.37e-06	4.74e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.3e-06	4.64e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	3.22e-06	4.53e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.14e-06	4.41e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.06e-06	4.3e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.97e-06	4.18e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.8e-06	3.95e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.75e-06	3.87e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.74e-06	3.85e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.53e-06	3.55e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.11e-06	2.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.95e-06	2.74e-05	CbGpPWpGaD
